Lu Pei
Impact in
-
- Hepatitis C virus research
Papers in
-
- Glycosylation and Glycoproteins Research 3
- RNA modifications and cancer 2
-
- Immunotherapy and Immune Responses 5
- Immune Response and Inflammation 2
- Co-authors
- Liping Dai (5 shared papers)Jianying Zhang (5 shared papers)Hongchun Liu (3 shared papers)Kaijuan Wang (4 shared papers)Hua Ye (4 shared papers)Tingting Wang (4 shared papers)Peng Wang (3 shared papers)Man Liu (3 shared papers)
In The Last Decade
Lu Pei
15 papers receiving 225 citations
Peers
Comparison fields: 5 of 53
- Transplantation 12
- Hepatology 23
- Oncology 73
- Cancer Research 36
- Immunology 42
Countries citing papers authored by Lu Pei
This map shows the geographic impact of Lu Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Pei more than expected).
Fields of papers citing papers by Lu Pei
This network shows the impact of papers produced by Lu Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Pei. The network helps show where Lu Pei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 33 | |
| 2 | 2019 | 30 | |
| 3 | 2017 | 24 | |
| 4 | 2019 | 23 | |
| 5 | 2019 | 23 | |
| 6 | 2017 | 22 | |
| 7 | 2021 | 20 | |
| 8 | 2022 | 13 | |
| 9 | 2023 | 12 | |
| 10 | [Prophylactic effect of amifostine on oxaliplatin-related neurotoxicity in patients with digestive tract tumors]. | 2008 | 11 |
| 11 | 2017 | 6 | |
| 12 | 2014 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2025 | 2 | |
| 15 | 2023 | 1 | |
| 16 | 2024 | 0 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Lu Pei
Lu Pei is a scholar working on Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 227 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer Treatment and Pharmacology (2 papers), Oral microbiology and periodontitis research (2 papers), Immune Response and Inflammation (2 papers), RNA modifications and cancer (2 papers) and Acne and Rosacea Treatments and Effects (1 paper). The work is most often cited by research in Transplantation (12 citations), Hepatology (23 citations), Oncology (73 citations), Cancer Research (36 citations) and Immunology (42 citations). Lu Pei has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Liping Dai, Jianying Zhang, Hongchun Liu, Kaijuan Wang, Hua Ye, Tingting Wang, Peng Wang, Man Liu, Songyun Ouyang and Hong Zong. Their work appears in journals such as Frontiers in Immunology, Immunobiology, Medicine, Analytical Chemistry and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.